In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest From E.ON

OliX Diversifies Into mRNA Amid Growing Global Interest

Amid the highly successful launch of COVID-19 vaccines using the technology by Pfizer/BioNTech and Moderna, South Korean bioventure OliX Pharmaceuticals is diversifying into the mRNA field by establishing a new subsidiary that focuses on R&D into new vaccines and therapeutics using the platform.

South Korea Research and Development Strategies

Price Cuts For Daewoong As Korea Attacks Rebates

South Korea's Ministry of Health and Welfare will cut the prices of five products from Daewoong Pharmaceutical by 20% from May following a Seoul court's ruling last year that found the pharma firm guilty of providing illegal rebates in return for prescriptions.

BioPharmaceutical South Korea

Wright Buys French Extremities Device Firm For $75 Million Upfront

The acquisition of Biotech International is intended to provide Wright with a complementary extremity product portfolio and to significantly expand Wright’s direct sales channel in France and international distribution network for foot and ankle products.

Medical Device Business Strategies

Extremities, Emerging Markets Continue To Top Ortho M&As

With hip and knee joint markets still registering slow to modest growth, orthopedic companies looking to add bulk to their bottom line through mergers and acquisitions have pursued two distinct directions – the extremities and emerging markets.

Medical Device
See All

Company Information

UsernamePublicRestriction

Register